51 results
8-K
EX-99.1
PLSE
Pulse Biosciences, Inc.
11 Mar 24
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
9:10am
Biosciences. “Internally, our team is pleased with its manufacturing and operational readiness as we initiate our training and commercialization programs
8-K
juq8xm5 uydyt3s02u
27 Sep 22
Departure of Directors or Certain Officers
5:42pm
8-K
EX-99.1
27iorso
23 Sep 22
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
5:09pm
8-K
6mkw3z 41l
23 Sep 22
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
5:09pm
8-K
EX-99.1
os5jz25dmkto
15 Feb 22
Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer
9:26am